NEW YORK (dpa-AFX Broker) - The US analyst firm Bernstein Research has added Carl Zeiss Meditec to its rating with an "Underperform" and a price target of 76 euros. The ophthalmology market is attractive, wrote analyst Susannah Ludwig in a study published on Tuesday. Carl Zeiss is a leader in terms of innovation, but the road ahead is challenging in view of the high investments required and the market entry in the USA. The medical technology provider is also facing strong headwinds from the Chinese market in the near future, which accounts for around a quarter of sales./bek/ajx

Publication of the original study: 22/01/2024 / 15:32 / UTC First dissemination of the original study: 22/01/2024 / 16:34 / UTC

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------